Lazard Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117M | Buy |
1,924,036
+368,193
| +24% | +$21.5M | 0.19% | 116 |
|
|
2025
Q4 | $83.9M | Buy |
1,555,843
+1,158,973
| +292% | +$55.8M | 0.14% | 155 |
|
|
2025
Q3 | $17.9M | Buy |
396,870
+21,733
| +6% | +$1.01M | 0.02% | 328 |
|
|
2025
Q2 | $17.4M | Buy |
375,137
+84,484
| +29% | +$4.15M | 0.02% | 435 |
|
|
2025
Q1 | $17.7M | Sell |
290,653
-88,672
| -23% | -$5.17M | 0.03% | 380 |
|
|
2024
Q4 | $21.5M | Sell |
379,325
-300,150
| -44% | -$16.8M | 0.03% | 329 |
|
|
2024
Q3 | $35.2M | Sell |
679,475
-1,006,807
| -60% | -$47.2M | 0.05% | 251 |
|
|
2024
Q2 | $70M | Sell |
1,686,282
-44,973
| -3% | -$2.01M | 0.09% | 173 |
|
|
2024
Q1 | $93.9M | Buy |
1,731,255
+588,799
| +52% | +$30M | 0.11% | 142 |
|
|
2023
Q4 | $58.6M | Buy |
1,142,456
+198,701
| +21% | +$10.4M | 0.07% | 196 |
|
|
2023
Q3 | $54.8M | Sell |
943,755
-58,150
| -6% | -$3.56M | 0.07% | 190 |
|
|
2023
Q2 | $64.1M | Buy |
1,001,905
+62,108
| +7% | +$4.16M | 0.08% | 189 |
|
|
2023
Q1 | $65.1M | Sell |
939,797
-11,117
| -1% | -$784K | 0.09% | 194 |
|
|
2022
Q4 | $68.4M | Buy |
950,914
+34,636
| +4% | +$2.61M | 0.09% | 185 |
|
|
2022
Q3 | $65.1M | Buy |
916,278
+201,542
| +28% | +$14.6M | 0.1% | 195 |
|
|
2022
Q2 | $55M | Buy |
714,736
+97,765
| +16% | +$7.45M | 0.07% | 222 |
|
|
2022
Q1 | $45.1M | Sell |
616,971
-909
| -0.1% | -$61K | 0.05% | 283 |
|
|
2021
Q4 | $38.5M | Sell |
617,880
-126,558
| -17% | -$7.42M | 0.04% | 347 |
|
|
2021
Q3 | $44M | Sell |
744,438
-82,000
| -10% | -$5.4M | 0.05% | 310 |
|
|
2021
Q2 | $55.2M | Sell |
826,438
-244,138
| -23% | -$15.9M | 0.06% | 257 |
|
|
2021
Q1 | $67.6M | Sell |
1,070,576
-151,599
| -12% | -$9.43M | 0.08% | 204 |
|
|
2020
Q4 | $75.8M | Sell |
1,222,175
-107,883
| -8% | -$6.63M | 0.1% | 181 |
|
|
2020
Q3 | $80.2M | Buy |
1,330,058
+28,421
| +2% | +$1.71M | 0.11% | 152 |
|
|
2020
Q2 | $76.5M | Buy |
1,301,637
+35,001
| +3% | +$2.09M | 0.12% | 151 |
|
|
2020
Q1 | $70.6M | Sell |
1,266,636
-193,297
| -13% | -$11.8M | 0.13% | 129 |
|
|
2019
Q4 | $93.7M | Buy |
1,459,933
+207,050
| +17% | +$11.9M | 0.13% | 134 |
|
|
2019
Q3 | $63.5M | Sell |
1,252,883
-50,597
| -4% | -$2.38M | 0.1% | 154 |
|
|
2019
Q2 | $59.1M | Buy |
1,303,480
+102,511
| +9% | +$4.77M | 0.1% | 159 |
|
|
2019
Q1 | $57.3M | Buy |
1,200,969
+391,918
| +48% | +$19.5M | 0.09% | 152 |
|
|
2018
Q4 | $42.1M | Sell |
809,051
-114,521
| -12% | -$6.15M | 0.08% | 173 |
|
|
2018
Q3 | $57.3M | Sell |
923,572
-155,565
| -14% | -$9.23M | 0.09% | 156 |
|
|
2018
Q2 | $59.7M | Buy |
1,079,137
+46,441
| +4% | +$2.51M | 0.1% | 153 |
|
|
2018
Q1 | $65.3M | Sell |
1,032,696
-67,829
| -6% | -$4.36M | 0.11% | 141 |
|
|
2017
Q4 | $67.4M | Buy |
1,100,525
+239,640
| +28% | +$15M | 0.12% | 139 |
|
|
2017
Q3 | $54.9M | Buy |
860,885
+131,428
| +18% | +$7.67M | 0.1% | 142 |
|
|
2017
Q2 | $40.6M | Sell |
729,457
-202,504
| -22% | -$11M | 0.08% | 177 |
|
|
2017
Q1 | $50.7M | Sell |
931,961
-754,297
| -45% | -$41.4M | 0.1% | 148 |
|
|
2016
Q4 | $98.5M | Sell |
1,686,258
-562,716
| -25% | -$30.8M | 0.2% | 89 |
|
|
2016
Q3 | $121M | Sell |
2,248,974
-206,128
| -8% | -$13.2M | 0.24% | 84 |
|
|
2016
Q2 | $181M | Sell |
2,455,102
-194,721
| -7% | -$13.8M | 0.38% | 72 |
|
|
2016
Q1 | $169M | Sell |
2,649,823
-59,591
| -2% | -$3.76M | 0.37% | 72 |
|
|
2015
Q4 | $186M | Sell |
2,709,414
-451,110
| -14% | -$29.8M | 0.43% | 68 |
|
|
2015
Q3 | $187M | Sell |
3,160,524
-1,147,183
| -27% | -$72.8M | 0.45% | 67 |
|
|
2015
Q2 | $287M | Sell |
4,307,707
-280,225
| -6% | -$18.5M | 0.6% | 42 |
|
|
2015
Q1 | $296M | Sell |
4,587,932
-91,079
| -2% | -$5.7M | 0.64% | 41 |
|
|
2014
Q4 | $276M | Sell |
4,679,011
-402,943
| -8% | -$22.7M | 0.59% | 47 |
|
|
2014
Q3 | $260M | Sell |
5,081,954
-316,789
| -6% | -$15.8M | 0.56% | 51 |
|
|
2014
Q2 | $262M | Buy |
5,398,743
+25,837
| +0.5% | +$1.27M | 0.55% | 56 |
|
|
2014
Q1 | $279M | Sell |
5,372,906
-224,371
| -4% | -$11.9M | 0.62% | 44 |
|
|
2013
Q4 | $297M | Buy |
5,597,277
+173,564
| +3% | +$8.84M | 0.66% | 44 |
|
|
2013
Q3 | $251M | Buy |
5,423,713
+868,548
| +19% | +$38.1M | 0.6% | 50 |
|
|
2013
Q2 | $204M | Buy |
+4,555,165
| New | +$198M | 0.48% | 61 |
|
Other funds holding BMY
VCM
VPM
Lazard Asset Management's BMY Position: Q1 2026 in Review
Lazard Asset Management increased its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, buying an estimated $21.5M and bringing the position to 1,924,036 shares worth $117M. The position accounts for 0.19% of the portfolio, ranked #116.
Lazard Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $297M in Q4 2013. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Lazard Asset Management held 1,924,036 shares of Bristol-Myers Squibb worth $117M as of Q1 2026.
- Lazard Asset Management bought 368,193 Bristol-Myers Squibb shares in Q1 2026, an estimated $21.5M.
- Bristol-Myers Squibb made up 0.19% of Lazard Asset Management's portfolio in Q1 2026, its #116 holding.
- Lazard Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Bristol-Myers Squibb position peaked at $297M in Q4 2013.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.